Hereditary Apolipoprotein A-I-Associated Cardiac Amyloidosis: Importance of Endomyocardial Biopsy When Suspicion Remains High.
JACC Case Rep
; 3(7): 1032-1037, 2021 Jul 07.
Article
en En
| MEDLINE
| ID: mdl-34317679
Cardiac amyloidosis has recently garnered substantial attention. Although the advent of noninvasive diagnostic algorithms revolutionized diagnosis, endomyocardial biopsy may still be considered in select cases to determine the amyloidosis subtype definitively. We report a case of a patients with a known mutation causing hereditary apolipoprotein A-I-associated cardiac amyloidosis. (Level of Difficulty: Advanced.).
AApo A-I, amyloid apolipoprotein A-I; AL, immunoglobulin light chain; ATTR, amyloid transthyretin; CA, cardiac amyloidosis; CMR, cardiac magnetic resonance; EMB, endomyocardial biopsy; HCM, hypertrophic cardiomyopathy; HFpEF, heart failure with preserved ejection fraction; LC MS/MS, liquid chromatography tandem mass spectrometry; apolipoprotein; endomyocardial biopsy; infiltrative cardiomyopathy
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Risk_factors_studies
Idioma:
En
Revista:
JACC Case Rep
Año:
2021
Tipo del documento:
Article
País de afiliación:
Estados Unidos
Pais de publicación:
Países Bajos